The application relates to a lipid conjugate of formula M-X1-L wherein M is a molecule of interest such as a drug moiety; X1 is a linker group such as ester, ether or carbamate; and L is a lipid scaffold represented by formula (lId): -L1-[L2(H)(X2R)]n-L3-[L4(H)(X2R)]p-L5-L6 and wherein L comprises 5 to 40 carbon atoms and 0 to 2 carbon-carbon double bonds. The lipid conjugate can be formulated in a drug delivery vehicle such as a lipid nanoparticle (LNP).
该应用涉及公式M-X1-L的脂质共轭物,其中M是感兴趣的分子,如药物基团;X1是连接基团,如酯、醚或
氨基甲酸酯;L是由公式(lId)表示的脂质支架:-L1-[
L2(H)(X2R)]n-L3-[L4(H)(X2R)]p-L5-L6,其中L包含5至40个碳原子和0至2个碳-碳双键。该脂质共轭物可以配制在药物传递载体中,如脂质纳米粒子(LNP)。